AR063638A1 - Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion - Google Patents
Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacionInfo
- Publication number
- AR063638A1 AR063638A1 ARP070105002A ARP070105002A AR063638A1 AR 063638 A1 AR063638 A1 AR 063638A1 AR P070105002 A ARP070105002 A AR P070105002A AR P070105002 A ARP070105002 A AR P070105002A AR 063638 A1 AR063638 A1 AR 063638A1
- Authority
- AR
- Argentina
- Prior art keywords
- substituted
- alkyl
- group
- heteroaryl
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C273/00—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C273/18—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Reivindicación 1: Producto de fórmula general (1) siguiente en la que 1) A y Ar se seleccionan independientemente del grupo constituido por arilo, heteroarilo, arilo sustituido, heteroarilo sustituido; 2) L se selecciona del grupo constituido por NH- CO-NH y O-CO-NH; 3) R1 se selecciona del grupo constituido por H, R6, COR6, SO2R6, en el que R6 se elige entre H, OR7, NR8R9, alquilo, cicloalquilo, heterociclilo sustituido, arilo, arilo sustituido, heteroarilo, heteroarilo sustituido, en el que R7 se elige entre H, fenilo, alquilo, y en el que R8, y R9 se seleccionan independientemente del grupo constituido por H, alquilo, cicloalquilo, heterociclilo, heterociclilo sustituido, arilo, arilo sustituido, heteroarilo, heteroarilo sustituido o bien R8 y R9 están unidos cutre si para formar un ciclo saturado de 5 a 8 eslabones que contiene de 0 a 3 heteroátomos elegidos entre O, S y N; 4) X se selecciona del grupo constituido por O y NH, 5) R3 se selecciona del grupo constituido por H, alquilo, aIquilo sustituido, cicloalquilo, cicloalquilo sustituido; 6) R4a se selecciona del grupo constituido por: H o alquilo C1-4; 7) R4b se selecciona del grupo constituido por H o alquilo C1-4; 8) R5 se selecciona del grupo constituido por H, halógeno, R10, CN, O(R10), OC(O)(R10), OC(O)N(R10)(R11), OS(O2)(R10), N(R10)(R11), N=C(R10)(R11), N(R10)C(O)(R11), N(R10)C(O)O(R11), N(R12)C(O)N(R10)(R11), N(R12)C(S)N(R10)(R11), N(R10)S(O2)(R11), C(O)(R10), C(O)O(R10), C(O)N(R10)(R11), C(=N(R11))(R10), C(=N(OR11))(R10), S(R10), S(O)(R10), S(O2)(R10), S(O2)O(R10), S(O2)N(R10)(R11); en el que cada R10, R11, R12 se selecciona independientemente del pupo constituido por H, alquilo, alquileno, alquinilo, arilo, heteroarilo, cicloalquilo, heterociclilo, alquilo sustituido, alquileno sustituido, alquinilo sustituido, arilo sustituido, heteroarilo sustituido, cicloalquilo sustituido y heterociclilo sustituido.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0609812A FR2908409B1 (fr) | 2006-11-10 | 2006-11-10 | Pyrazoles substituees,compositions les contenant,procede de fabrication et utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR063638A1 true AR063638A1 (es) | 2009-02-04 |
Family
ID=38169388
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070105002A AR063638A1 (es) | 2006-11-10 | 2007-11-09 | Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion |
Country Status (40)
| Country | Link |
|---|---|
| US (3) | US7989439B2 (es) |
| EP (1) | EP2091920B1 (es) |
| JP (1) | JP5538893B2 (es) |
| KR (1) | KR20090083456A (es) |
| CN (1) | CN101553473B (es) |
| AR (1) | AR063638A1 (es) |
| AU (1) | AU2007327423B2 (es) |
| BR (1) | BRPI0718999A2 (es) |
| CA (1) | CA2667846A1 (es) |
| CL (1) | CL2007003251A1 (es) |
| CO (1) | CO6190516A2 (es) |
| CR (1) | CR10749A (es) |
| CY (1) | CY1116000T1 (es) |
| DK (1) | DK2091920T3 (es) |
| DO (1) | DOP2009000088A (es) |
| EA (1) | EA019454B1 (es) |
| EC (1) | ECSP099312A (es) |
| ES (1) | ES2528385T3 (es) |
| FR (1) | FR2908409B1 (es) |
| HK (1) | HK1137988A1 (es) |
| HN (1) | HN2009000856A (es) |
| HR (1) | HRP20150070T1 (es) |
| IL (1) | IL198328A0 (es) |
| MA (1) | MA30972B1 (es) |
| MX (1) | MX2009004983A (es) |
| MY (1) | MY147502A (es) |
| NI (1) | NI200900078A (es) |
| NO (1) | NO20091990L (es) |
| NZ (1) | NZ576709A (es) |
| PE (2) | PE20121152A1 (es) |
| PL (1) | PL2091920T3 (es) |
| PT (1) | PT2091920E (es) |
| SI (1) | SI2091920T1 (es) |
| SV (1) | SV2009003253A (es) |
| TN (1) | TN2009000155A1 (es) |
| TW (1) | TW200829556A (es) |
| UA (1) | UA97965C2 (es) |
| UY (1) | UY30707A1 (es) |
| WO (1) | WO2008065282A2 (es) |
| ZA (1) | ZA200903560B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7858323B2 (en) * | 2004-06-09 | 2010-12-28 | The Regents Of The University Of Michigan | Phage microarray profiling of the humoral response to disease |
| FR2947546B1 (fr) * | 2009-07-03 | 2011-07-01 | Sanofi Aventis | Derives de pyrazoles, leur preparation et leur application en therapeutique |
| AR079967A1 (es) * | 2010-01-26 | 2012-02-29 | Sanofi Aventis | Derivados de acido 3-heteroaroilamino-propionico sustituidos con oxigeno y su uso como productos farmaceuticos |
| TWI523844B (zh) | 2011-01-26 | 2016-03-01 | 賽諾菲公司 | 經胺基取代之３－雜芳醯基胺基－丙酸衍生物及其作為藥物之用途 |
| CN102432639B (zh) * | 2011-09-30 | 2013-11-06 | 山东大学 | 1-(2-羟基-3-(苯氨基)丙基)-3-二茂铁基-1h-吡唑-5-甲酸乙酯化合物及其应用 |
| MD20150035A2 (ro) | 2012-11-02 | 2015-10-31 | Pfizer Inc. | Inhibitori de tirozinkinaza Bruton |
| RU2017134379A (ru) | 2015-03-25 | 2019-04-03 | Новартис Аг | Формилированные n-гетероциклические производные в качестве ингибиторов fgfr4 |
| CN107619388A (zh) * | 2016-07-13 | 2018-01-23 | 南京天印健华医药科技有限公司 | 作为fgfr抑制剂的杂环化合物 |
| CN107840842A (zh) | 2016-09-19 | 2018-03-27 | 北京天诚医药科技有限公司 | 炔代杂环化合物、其制备方法及其在医药学上的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6878714B2 (en) * | 2001-01-12 | 2005-04-12 | Amgen Inc. | Substituted alkylamine derivatives and methods of use |
| EP1461334A2 (en) * | 2001-04-27 | 2004-09-29 | Vertex Pharmaceuticals Incorporated | Pyrazole derived kinase inhibitors |
| ATE390422T1 (de) * | 2003-04-16 | 2008-04-15 | Astrazeneca Ab | Quinazolin-derivate für die behandling von krebs |
| US20040220186A1 (en) * | 2003-04-30 | 2004-11-04 | Pfizer Inc. | PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease |
| MXPA06000794A (es) * | 2003-07-22 | 2006-08-23 | Astex Therapeutics Ltd | Compuestos 1h-pirazola 3,4-disustituida y su uso como moduladores de quinasas dependientes de ciclina (cdk) y quinasa-3 de sintasa de glicogeno (gsr-3). |
| US20080004270A1 (en) * | 2004-07-05 | 2008-01-03 | Astex Therapeutics Limited | 3,4-Disubstituted Pyrazoles as Cyclin Dependent Kinases (Cdk) or Aurora Kinase or Glycogen Synthase 3 (Gsk-3) Inhibitors |
| EP1786422A2 (en) * | 2004-08-16 | 2007-05-23 | Prosidion Limited | Aryl urea derivatives for treating obesity |
| US20100160324A1 (en) * | 2004-12-30 | 2010-06-24 | Astex Therapeutics Limited | Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases |
| CN101146533A (zh) * | 2005-01-21 | 2008-03-19 | 阿斯泰克斯治疗有限公司 | 吡唑激酶抑制剂和其它抗肿瘤剂的组合 |
| AR052660A1 (es) * | 2005-01-21 | 2007-03-28 | Astex Therapeutics Ltd | Derivados de pirazol para inhibir la cdk's y gsk's |
| EP1683796A1 (en) * | 2005-01-24 | 2006-07-26 | Schering Aktiengesellschaft | Pyrazolopyridines, their preparation and their medical use |
| FR2947546B1 (fr) * | 2009-07-03 | 2011-07-01 | Sanofi Aventis | Derives de pyrazoles, leur preparation et leur application en therapeutique |
-
2006
- 2006-11-10 FR FR0609812A patent/FR2908409B1/fr not_active Expired - Fee Related
-
2007
- 2007-11-08 TW TW096142249A patent/TW200829556A/zh unknown
- 2007-11-09 ZA ZA200903560A patent/ZA200903560B/xx unknown
- 2007-11-09 PE PE2012000296A patent/PE20121152A1/es not_active Application Discontinuation
- 2007-11-09 PE PE2007001548A patent/PE20081162A1/es not_active Application Discontinuation
- 2007-11-09 UA UAA200905930A patent/UA97965C2/ru unknown
- 2007-11-09 BR BRPI0718999-0A2A patent/BRPI0718999A2/pt not_active IP Right Cessation
- 2007-11-09 MX MX2009004983A patent/MX2009004983A/es active IP Right Grant
- 2007-11-09 DK DK07870263.6T patent/DK2091920T3/en active
- 2007-11-09 KR KR1020097011936A patent/KR20090083456A/ko active IP Right Grant
- 2007-11-09 AR ARP070105002A patent/AR063638A1/es not_active Application Discontinuation
- 2007-11-09 PL PL07870263T patent/PL2091920T3/pl unknown
- 2007-11-09 CA CA002667846A patent/CA2667846A1/fr not_active Abandoned
- 2007-11-09 JP JP2009535773A patent/JP5538893B2/ja not_active Expired - Fee Related
- 2007-11-09 UY UY30707A patent/UY30707A1/es not_active Application Discontinuation
- 2007-11-09 NZ NZ576709A patent/NZ576709A/en not_active IP Right Cessation
- 2007-11-09 SI SI200731592T patent/SI2091920T1/sl unknown
- 2007-11-09 WO PCT/FR2007/001851 patent/WO2008065282A2/fr active Application Filing
- 2007-11-09 MY MYPI20091827A patent/MY147502A/en unknown
- 2007-11-09 EP EP07870263.6A patent/EP2091920B1/fr active Active
- 2007-11-09 PT PT78702636T patent/PT2091920E/pt unknown
- 2007-11-09 CL CL2007003251A patent/CL2007003251A1/es unknown
- 2007-11-09 ES ES07870263.6T patent/ES2528385T3/es active Active
- 2007-11-09 AU AU2007327423A patent/AU2007327423B2/en not_active Ceased
- 2007-11-09 EA EA200970472A patent/EA019454B1/ru not_active IP Right Cessation
- 2007-11-09 CN CN200780045533XA patent/CN101553473B/zh not_active Expired - Fee Related
-
2009
- 2009-04-23 DO DO2009000088A patent/DOP2009000088A/es unknown
- 2009-04-23 IL IL198328A patent/IL198328A0/en unknown
- 2009-04-24 CR CR10749A patent/CR10749A/es unknown
- 2009-04-24 TN TNP2009000155A patent/TN2009000155A1/fr unknown
- 2009-05-05 EC EC2009009312A patent/ECSP099312A/es unknown
- 2009-05-06 NI NI200900078A patent/NI200900078A/es unknown
- 2009-05-07 SV SV2009003253A patent/SV2009003253A/es unknown
- 2009-05-07 CO CO09046036A patent/CO6190516A2/es active IP Right Grant
- 2009-05-08 US US12/437,618 patent/US7989439B2/en not_active Expired - Fee Related
- 2009-05-08 HN HN2009000856A patent/HN2009000856A/es unknown
- 2009-05-22 NO NO20091990A patent/NO20091990L/no not_active Application Discontinuation
- 2009-06-05 MA MA31959A patent/MA30972B1/fr unknown
-
2010
- 2010-03-26 HK HK10103174.0A patent/HK1137988A1/xx not_active IP Right Cessation
-
2011
- 2011-06-09 US US13/156,915 patent/US8410286B2/en not_active Expired - Fee Related
- 2011-06-09 US US13/156,947 patent/US8420824B2/en not_active Expired - Fee Related
-
2015
- 2015-01-20 HR HRP20150070TT patent/HRP20150070T1/hr unknown
- 2015-01-22 CY CY20151100068T patent/CY1116000T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR063638A1 (es) | Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion | |
| PE20191541A1 (es) | Composiciones y metodos para inhibir la accion de la arginasa | |
| PA8651001A1 (es) | Compuestos quimicos | |
| PE20131165A1 (es) | Analogos de carba-nucleosidos sustituidos con 2'-fluoro para tratamiento antiviral | |
| PE20081448A1 (es) | Inhibidores de transcriptasa inversa no nucleosidicos | |
| AR040668A1 (es) | Piridinas y pirimidinas 4- trifluormetilpirazolil sustituidas | |
| AR052866A1 (es) | Fenil-metanonas monociclicas sustituidas | |
| NI201000150A (es) | Nuevos derivados de carbazol, inhibidores de hsp90, composiciones que los contienen y utilización. | |
| EA200800172A1 (ru) | 2,4-диаминопиримидины как ингибиторы aurora | |
| PE20140171A1 (es) | Pirazoles fungicidas y sus mezclas | |
| CO6160235A2 (es) | Isoxazolinas insecticidas | |
| AR052357A1 (es) | Pirazolo piridinas sustituidas moduladoras de la actividad de quinasas | |
| AR045687A1 (es) | Macrociclos derivados de la quinazolina, procesos de preparacion y composiciones farmaceuticas que los contienen | |
| CY1113560T1 (el) | Αζαϊνδολια χρησιμα ως αναστολεις των jak και αλλων πρωτεϊνικων κινασων | |
| MX337516B (es) | Derivados de 1,2,4-tiazolidin-3-ona y uso en el tratamiento del cancer. | |
| EA200870192A1 (ru) | Новые серосодержащие производные циклической мочевины, их получение и их фармацевтическое применение в качестве ингибиторов киназ | |
| PE20110546A1 (es) | Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk) y produccion de los mismos | |
| AR078270A1 (es) | Inhibidores de jak (quinasas janus) | |
| PE20091426A1 (es) | Compuestos de piridina | |
| MX2016017405A (es) | Compuestos derivados de 2-(3-piridinil)-1h-benzimidazol y medicamentos que los contienen. | |
| AR044830A1 (es) | Derivados de 4,5 diaril -3-heterociclilpirazin- 2- ester | |
| PE20080929A1 (es) | Metodos para el tratamiento de la depresion | |
| SE0403085D0 (sv) | Novel componds | |
| AR052571A1 (es) | Pirroles sustituidos, composiciones que los contienen , proceso de fabricacion y utilizacion | |
| TW200745048A (en) | Novel benzimidazole and benzothiazole derivatives, preparation process therefor, application thereof as medicaments, pharmaceutical compositions and novel use especially as CMET inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |